Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cuervo

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|October 29, 2024
Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19T F Aiello, C Teijon-Lumbreras, A Gallardo-Pizarro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2015
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strainsG Cuervo, M Puig-Asensio, C Garcia-Vidal, et al.
The Journal of Infectious Diseases|May 8, 2025
Time to reappraise the antibiotic treatment for methicillin-susceptible Staphylococcus aureus infective endocarditis: data from the experimental modelC García-de-la-Mària, O Gasch, M A Cañas, et al.
Implementation Science : IS|October 23, 2015
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trialsVivian Welch, J Jull, J Petkovic, et al.
Open Forum Infectious Diseases|June 9, 2021
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort StudiesE Moreno-García, P Puerta-Alcalde, G Gariup, et al.
Open Forum Infectious Diseases|May 26, 2022
Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort StudiesE Moreno-García, P Puerta-Alcalde, G Gariup, et al.
BMJ Open|September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual frameworkJ Jull, M Whitehead, M Petticrew, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|October 29, 2024
Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19T F Aiello, C Teijon-Lumbreras, A Gallardo-Pizarro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2015
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strainsG Cuervo, M Puig-Asensio, C Garcia-Vidal, et al.
The Journal of Infectious Diseases|May 8, 2025
Time to reappraise the antibiotic treatment for methicillin-susceptible Staphylococcus aureus infective endocarditis: data from the experimental modelC García-de-la-Mària, O Gasch, M A Cañas, et al.
Implementation Science : IS|October 23, 2015
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trialsVivian Welch, J Jull, J Petkovic, et al.
Open Forum Infectious Diseases|June 9, 2021
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort StudiesE Moreno-García, P Puerta-Alcalde, G Gariup, et al.
Open Forum Infectious Diseases|May 26, 2022
Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort StudiesE Moreno-García, P Puerta-Alcalde, G Gariup, et al.
BMJ Open|September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual frameworkJ Jull, M Whitehead, M Petticrew, et al.
Pageof 3